ISRCTN95974322
Completed
N/A
Immunogenicity and safety of Brazilian combined vaccine against diphtheria, tetanus, pertussis, haemophilus influenzae type B and hepatitis B (DTPw/HB/hib)
Bio-Manguinhos/Fiocruz (Brazil)0 sites1,200 target enrollmentJune 30, 2008
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Bio-Manguinhos/Fiocruz (Brazil)
- Enrollment
- 1200
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy newborns (newborns and infants up to 7 months of age, of both sexes) whose parents/tutors understand the risk and benefits of the trial and agree to participate with written and informed consent.
Exclusion Criteria
- •Newborns or mothers:
- •1\. Hepatitis B surface antigen (HBsAg) positive
- •2\. Human immunodeficiency virus (HIV) seropositive
- •3\. With positive serology for syphilis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Safety and immunogenicity of meningococcus C conjugate vaccineMeningococcus C diseaseInfections and InfestationsMeningococcal infectionISRCTN37262487Bio-Manguinhos/Fiocruz (Brazil)60
Completed
N/A
Safety, efficacy and immunogenicity of concomitant molecular target drug or cytokine therapy and autologous tumor lysate-pulsed dendritic cell therapy in patients with advanced renal cell carcinomaJPRN-UMIN000014703The University of Tokyo Hospital15
Completed
N/A
Safety, efficacy and immunogenicity of concomitant interferon alpha and autologous tumor lysate-pulsed dendritic cell therapy in patients with advanced renal cell carcinomaRenal cell carcinomaJPRN-UMIN000006646The University of Tokyo Hospital15
Not Yet Recruiting
Phase 1
CENTAURO-6 StudyHepatocellular carcinomaLiver NeoplasmsCarcinoma, HepatocellularDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialRPCEC00000237Center for Genetic Engineering and Biotechnology (CIGB), in Havana.20
Not Yet Recruiting
Phase 4
Immune response to polio vaccine in malnourished and normally nourished Pakistani infantspolio vaccine immunogenecityInfection - Other infectious diseasesPublic Health - Other public healthACTRN12612000259842WHO840